Table 1.

Patient-reported outcome measures, inflammatory markers, and composite scores of disease activity (n = 141).

VariableMedian (range)
Pain, 0–100 mm31 (0–93)
Joint pain, 0–100 mm31 (0–94)
PtGA, 0–100 mm32 (0–88)
EGA, 0–100 mm11 (0–64)
Fatigue, 0–100 mm42 (0–100)
Morning stiffness, 0–100 mm0.5 (0–6)
Back pain, 0–100 mm28 (0–100)
TJC 68, 0–686.0 (0–55)
SJC 66, 0–660 (0–6)
Dactylitis count, 0–200 (0–2)
MHAQ, 0–30.38 (0.0–2.63)
BASDAI, 0–103.1 (0.0–9.8)
BASFI, 0–102.1 (0.0–9.9)
CRP, mg/l2 (0–63)
ESR, mm/h13 (2–64)
DAPSA14.5 (0.1–76.4)
CPDAI, 0–155 (1–11)
CPDAI-JED, 0–94 (0–6)
PASDAS3.1 (2.1–4.2)
SDAI8.6 (0.1–39.5)
CDAI7.9 (0–39.4)
DAS28-CRP2.8 (1.0–5.9)
DAS28-ESR3.2 (0.6–6.4)
RAID, 0–103.3 (0.0–9.3)
MASES, 0–132 (0–13)
DLQI, 0–302.0 (0–17.0)
PASI, 0–721.2 (0.0–19.7)
  • PtGA: patient’s global assessment; EGA: evaluator’s global assessment; TJC 68: 68 tender joint count; SJC 66: 66 swollen joint count; MHAQ: modified health assessment questionnaire; BASDAI: Bath Ankylosing Spondylitis Disease Activity Index; BASFI: Bath Ankylosing Spondylitis Functional Index; CRP: C-reactive protein; ESR: erythrocyte sedimentation rate; DAPSA: Disease Activity Index for Psoriatic Arthritis; CPDAI: Composite Psoriatic Disease Activity Index; CPDAI-JED: joint, entheses, and dactylitis domains of CPDAI; PASDAS: Psoriatic Arthritis Disease Activity Score; SDAI: Simplified Disease Activity Index; CDAI: Clinical Disease Activity Index; DAS28-CRP(4): 28-joint Disease Activity Score with CRP and PtGA; DAS28-ESR(4): 28-joint DAS with ESR and PtGA; RAID: Rheumatoid Arthritis Impact of Disease; MASES: Maastricht Ankylosing Spondylitis Enthesitis Score; DLQI: Dermatology Life Quality Index; PASI: Psoriasis Area Severity Index.